← Leaderboards
Freddyson J Martinez-Rivera
Icahn School Of Medicine At Mount Sinai
$892,080
Attributed
$892,080
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $178.4K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$892,080 · 1
By mechanism
K01$892,080 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Paul J Kenny$51,539,568
- Eric J Nestler$73,310,132
- Yasmin L Hurd$58,238,356
- Anne Schaefer$13,330,813
- Ian S. Maze$11,831,307
Others in their field
Other Emerging Leaders on “Dopamine”
- Michael R Tadross · Duke University$8,054,116
- Jeffrey Reich · Sparian Biosciences, Inc.$6,903,733
- Kei M Igarashi · University Of California-Irvine$6,470,638
- Michael A Crickmore · Boston Children'S Hospital$6,251,848
- Stephan Lammel · University Of California Berkeley$6,045,969
- Xiaosi Gu · Icahn School Of Medicine At Mount Sinai$4,437,386
Research focus
DopamineAbstinenceDesignAwardAdverse OutcomeBehaviorAddictionBehavior TherapyBrainBrain RegionCellsCell TypeClinicClinically RelevantBehavioralAttenuatedCocaine Self-AdministrationCodeConflict (Psychology)CostCuesData SetDecision MakingDrug Seeking Behavior
Grant awards (5)
Transcriptional reprogramming of drug-associated memories in the nucleus accumbens$178,416
K01 · FY2025 · DA · contact PI
Transcriptional reprogramming of drug-associated memories in the nucleus accumbens$178,416
K01 · FY2024 · DA · contact PI
Transcriptional reprogramming of drug-associated memories in the nucleus accumbens$178,416
K01 · FY2023 · DA · contact PI
Transcriptional reprogramming of drug-associated memories in the nucleus accumbens$178,416
K01 · FY2022 · DA · contact PI
Transcriptional reprogramming of drug-associated memories in the nucleus accumbens$178,416
K01 · FY2021 · DA · contact PI